Effects of truck transportation and slaughtering on the occurrence of prednisolone and its metabolites in cow urine, liver, and adrenal glands by Capra, P. et al.
RESEARCH ARTICLE Open Access
Effects of truck transportation and
slaughtering on the occurrence of
prednisolone and its metabolites in
cow urine, liver, and adrenal glands
Pierluigi Capra1†, Marta Leporati1,2†, Carlo Nebbia3, Stefano Gatto4, Alberto Attucci5, Gandolfo Barbarino6 and
Marco Vincenti2,7*
Abstract
Background: The recognition of illegal administration of synthetic corticosteroids in animal husbandry has been
recently challenged by the case of prednisolone, whose occasional presence in the urine of bovines under strong
stressful conditions was attributed to endogenous biosynthesis, not to exogenous administration. The study of
the natural stress sources possibly inducing endogenous prednisolone production represents a stimulating
investigation subject. The biochemical effects of transportation and slaughtering were verified in untreated cows
by studying the possible occurrence of prednisolone and its metabolites in urine, liver and adrenal glands, and
the cortisol/cortisone quantification.
Results: Cortisol, cortisone, prednisolone and its metabolites were measured in urine, collected at farm under
natural micturition and then at the slaughterhouse. The study was performed on 15 untreated cows reared in
different farms at the end of their productive cycle. 2–3 days after the first urine collection, the animals were
transported by trucks to the abattoir, slaughtered, and subjected to a second urine sampling from the bladder.
Specimens of liver and adrenal gland were also collected and analysed by means of a liquid chromatography-
tandem mass spectrometry (LC-MS/MS) validated method. The stressful conditions of transportation and
slaughtering proved to increase considerably the urinary levels of cortisol and cortisone as compared to those
collected at farm. Prednisolone was detected in the urine collected at the slaughterhouse of two cows only, at
a concentration level (≈0.6 μg L− 1) largely below the official cut off (5.0 μg L− 1) established to avoid false non-
compliances. These two animals exhibited the highest urinary cortisol levels of the series. Prednisolone and
prednisone were also detected in the adrenal glands of a different cow. Prednisolone metabolites were not
detected in any urine, liver, and adrenal gland sample.
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Conclusion: Within the constraints of the condition adopted, this study confirms the sporadic presence of
prednisolone traces (2 samples out of 15) and the consistently increased concentration of cortisone and cortisol
in the urines collected from cows subjected to truck transportation and subsequent slaughtering. No prednisolone
metabolites were detected in any liver and adrenal gland samples, nor in urine specimens, unlike what was
previously reported for cows artificially stressed by pharmacological treatment.
Keywords: Glucocorticoids, Prednisolone, Stress, Slaughtering, Endogenous biosynthesis, Urine, Liver, Adrenal
glands, 20β-dehydroprednisolone
Background
A wide range of steroidal molecules have been synthe-
sized to replicate (with enhancement in efficiency and
duration) the anti-inflammatory properties of cortico-
steroids. Among the synthetic “corticosteroid-like”
molecules, prednisolone is the one with the chemical
structure most similar to the natural adrenal steroids.
Unlike betamethasone, dexamethasone and several
other synthetic molecules, prednisolone does not con-
tain any halogen atom and differs from cortisol
uniquely for the presence of a second double bound
on the A ring (Fig. 1).
Prednisolone and the other synthetic corticosteroids
can be used in veterinary therapy under strict medical
control to treat musculoskeletal and skin diseases,
allergic reactions and shock, and other pathologies [1, 2].
These drugs are also misused to conceal animal illness or
as growth-promoters, in which case they are administered
at sub-therapeutic doses. Their illegal use is monitored in
the EU area through National Residue Control Plans,
established according to the 96/23 EC directive.
In the last years, several research groups have inde-
pendently obtained experimental evidence consistent
with the possibility of endogenous/natural biosynthesis
of prednisolone, both in vitro [3] and in live animals
[4, 5]. Based on these evidences, the Italian Ministry
of Health [6] issued a technical note establishing a
precautionary threshold concentration of 5 μg L− 1 for pred-
nisolone in bovine urine. This threshold was subsequently
used as a legal cut-off to assess its unequivocal exogenous
origin. An identical threshold was proposed later by the
researchers of the E.U. Reference Laboratory [3].
In the frame of the project “Investigation on prednisolone
and its metabolites in meat and milk producing bovines,
assessment of endogenous biotransformation through “in
vivo” and “in vitro” experiments” supported by “Regione
Fig. 1 Molecular structures of the most commonly used synthetic corticosteroids, dexamethasone, betamethasone, and prednisolone,
highlighting the similarity between the latter and cortisol
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Piemonte–Direzione Sanità - Prevenzione Veterinaria”, a
study on 131 non treated cows was first carried out
throughout the years 2011/2012 in order to evaluate the
possible natural presence of prednisolone in their urine spe-
cimen. The presence of prednisolone at trace concentration
levels (i.e., 0.1–0.3 μg L− 1) was found in 7 animals only [7].
It is worth noting that all “positive” animals were reared in
loose housing systems, thereby experiencing significant
stress from the restraining and sample collection proce-
dures, as was reflected also in an increased urinary cor-
tisol concentration with respect to the animals usually
kept tethered. In the frame of the project mentioned
above, a characterization of the urinary excretion pro-
file of prednisolone was also performed in both healthy
finishing bulls and cows after the intramuscular (i.m.)
administration of a therapeutic schedule [8]. Among
the results of this kinetic study, it should be mentioned
that very low urinary cortisol and cortisone levels were
recorded at any checked time-point, along with a
consistent occurrence of 20β-dihydroprednisolone and,
more sporadically, other reduced or oxidized metabo-
lites of prednisolone and prednisone.
Endogenous prednisolone was found in the urines and
adrenal glands [9] of dairy cows subjected to the
distinctive state of stress consequent to their transport
and slaughter. More recently [10], the plasma pharmaco-
kinetic and urinary excretion profiles of relevant gluco-
corticoids were investigated in cattle subjected to either
exogenous prednisolone treatment or the administration
of synthetic ACTH analogue tetracosactide hexaacetate
to induce a stress allegedly leading to endogenous pred-
nisolone formation. The results of this study point to the
determination of the urinary prednisolone/cortisol ratio
as an expedient strategy to discriminate between en-
dogenous and exogenous prednisolone.
The present work was aimed at the evaluation of the
possible occurrence of prednisolone in urine, together
with the levels of cortisol and cortisone, arising from the
severe stressful conditions of transport and slaughtering
operation. A second objective was to assess the possible
presence of prednisolone metabolites (20α-dihydropred-
nisolone, 20β-dihydroprednisolone, 6β-hydroxypredniso
lone, 20β-dihydroprednisone) which have been so far as-
sociated with either therapeutic or illicit administration
of the drug. The last unprecedented goal was to target
the same prednisolone precursors and metabolites in
liver and adrenal glands as possible organs of prednisolone
biosynthesis.
Results
Adrenal gland method validation
Specificity
The SRM chromatographic profiles obtained from 10
adrenal glands samples did not reveal the presence of
any significant signal (S/N < 3) at the relative retention
time typical of the studied compounds and the internal
standards, with the exception of cortisol and cortisone.
Linearity
The calibration curves obtained for all the analytes
showed good fit and linearity over the entire range of
interest (Table 1), with the exception of cortisol and cor-
tisone. For these analytes the dynamic linear range
proved narrower than that initially planned (0.5–2.5 μg
L− 1 and 0.5–5.0 μg L− 1, respectively). The most likely
explanation for the calibration curve deflection is an
incomplete ionization that may occur at the highest con-
centrations. In practice, the real samples with cortisol or
cortisone concentration exceeding the linear range had
to be properly diluted in order to fall back into it.
Precision and trueness
Intraday data on precision and accuracy are reported in
Table 1. The results show satisfactory intra-day repeat-
ability, as the percent variation coefficient (CV%) was
lower than 15% for all the spiked analytes at low, inter-
mediate, and high concentration levels. Intraday results
also exhibited optimal trueness, as the percent bias fell
within few percent units in almost all cases, with
maximum experimental errors of − 13 and + 10%.
Real samples results
All the data collected for real samples are reported in
Table 2. In urine samples collected at farm, cortisol and
cortisone concentrations ranged from non-detectable to
3.5 μg L− 1 with the only exception of animal 13 whose
sample contained 24 μg L− 1 of cortisone and 52 μg L− 1 of
cortisol. Particularly laborious sampling operations were
recorded at farm for this animal that might explain the
unusually high levels for cortisol and cortisone detected in
this specific sample. None of the specimens collected at
farm contained measurable amounts of prednisone or
prednisolone. Truck transportation and slaughtering in-
deed induced a sharp increase in both urinary cortisol
(range 1.1÷145 μg L− 1, median 21 μg L− 1) and cortisone
(range from non-detectable to 53 μg L− 1, median 12 μg L−
1). In two samples (animals 2 and 15), that displayed the
highest concentrations of both cortisol and cortisone, the
presence of prednisolone was also detected at concentra-
tions of 0.57 and 0.60 μg L− 1, respectively.
One liver sample (animal 11) was found to contain
measurable amounts of cortisol (0.88 μg Kg− 1). The
other specimens were negative to all the measured
analytes.
Adrenal specimens exhibited uneven levels of corti-
sone and cortisol; in one animal (#12), prednisone and
prednisolone (Fig. 2) were detected at 3.4 μg Kg− 1 and
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Table 1 Validation results of the analytical method developed for adrenal glands. Intraday precision and accuracy were calculated at





















6β-hydroxyprednisolone 0.10–1.0 0.9953 – 6 8 8 – + 4 0 −7
20α-dihydroprednisolone 0.10–1.0 0.9906 – 9 5 12 – − 13 − 5 + 5
20β-dihydroprednisolone 0.10–1.0 0.9919 – 11 10 12 – + 4 + 1 −1
20β-dihydroprednisone 0.10–1.0 0.9900 – 8 9 7 – −9 −6 + 5
Prednisolone 0.025–0.50 0.9988 6 8 7 – + 10 + 6 + 4 –
Prednisone 0.025–0.50 0.9995 11 5 9 – + 7 + 3 + 1 –
Cortisol 0.50–2.5 0.9962
Cortisone 0.50–5.0 0.9983
Table 2 Analytical results obtained for urine and adrenal gland samples. Unavailable samples are indicated with N.A., while N.D.
stays for “not detectable”
Urine samples
Animal Cortisone (μg L−1) Cortisol (μg L− 1) Prednisone (μg L− 1) Prednisolone (μg L− 1)
Farm Slaughterhouse Farm Slaughterhouse Farm Slaughterhouse Farm Slaughterhouse
1 N.D. 16 N.D. 23 N.D. N.D. N.D. N.D.
2 1.5 49 N.D. 98 N.D. N.D. N.D. 0.57
3 N.A. 6.5 N.A. 9.1 N.A. N.D. N.A. N.D.
4 N.A. 18 N.A. 45 N.A. N.D. N.A. N.D.
5 N.D. N.D. 0.68 1.1 N.D. N.D. N.D. N.D.
6 N.D. 5.3 1.5 12 N.D. N.D. N.D. N.D.
7 1.1 1.6 2.1 2.6 N.D. N.D. N.D. N.D.
8 N.D. 3.9 N.D. 7.8 N.D. N.D. N.D. N.D.
9 N.D. 8.5 N.D. 15 N.D. N.D. N.D. N.D.
10 0.69 25 1.1 44 N.D. N.D. N.D. N.D.
11 N.D. 16 N.D. 21 N.D. N.D. N.D. N.D.
12 1.4 3.6 3.5 5.2 N.D. N.D. N.D. N.D.
13 24 12 52 31 N.D. N.D. N.D. N.D.
14 0.60 16 1.0 32 N.D. N.D. N.D. N.D.
15 1.6 53 2.4 145 N.D. N.D. N.D. 0.60
Adrenal glands samples
Animal Cortisone (μg Kg−1) Cortisol (μg Kg−1) Prednisone (μg Kg−1) Prednisolone (μg Kg−1)
1 476 150 N.D. N.D.
2 682 905 N.D. N.D.
3 1102 738 N.D. N.D.
4 615 230 N.D. N.D.
10 485 145 N.D. N.D.
11 286 46 N.D. N.D.
12 437 185 3.4 4.2
13 43 12 N.D. N.D.
14 38 7.5 N.D. N.D.
15 85 23 N.D. N.D.
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4.2 μg Kg− 1 respectively), but the corresponding urines
proved negative for both compounds.
Discussion
The data from this study further confirm that, under
conventional breeding conditions, no prednisolone or
very limited amounts of it can be synthesized in cows
and excreted in urine. Interestingly, no traces of prednis-
olone/prednisone nor their examined metabolites were
found in the urines collected from cows sampled at farm
and also negligible levels of cortisol and cortisone were
recorded. In agreement with the results of previous
studies [4, 9, 11], our findings confirm that stressful
events such as truck transportation followed by slaugh-
tering increase the urinary levels of cortisol and corti-
sone up to several times as compared to those collected
at farm. In our study, such a dramatic increase of corti-
sone and cortisol levels was associated with the produc-
tion of prednisolone in only two animals out of fifteen,
notably those whose urine contained the highest concen-
trations of cortisol (145 and 98 μg L− 1). Remarkably, the
prednisolone concentration measured in these two cases
(0.57 and 0.60 μg L− 1) was about one order of magnitude
below the official threshold of 5.0 μg L− 1 set by the
Italian Ministry of Health. In both “positive” urine
samples, the cortisol/prednisolone ratio appeared to be
reversed with respect to that displayed by animals sub-
mitted to exogenous prednisolone administration for
either therapeutic or growth-promoting purposes, when
the presence of prednisolone and its metabolites was
combined with low cortisol levels [8].
An important result of the present study is that nei-
ther the urine samples collected at farm nor those taken
from slaughtered animals were found to contain measur-
able amounts of 20β-dihydroprednisolone, namely the
most abundant urinary metabolite of prednisolone. Our
results are corroborated by a previous investigation [11]
in which neither 20α- nor 20β-dihydroprednisolone were
detected in urines collected in “naturally stressed”
bovines, namely 64 cows and 34 bulls after slaughtering.
Likewise, Leporati et al. [12] reported that no 20β-dihy-
droprednisolone nor any other prednisolone metabolites
were found, even at trace levels, in the urine samples
from 108 allegedly stressed cows involved in the “Bataille
Fig. 2 Selected ion chromatograms of the SRM transitions between the [M-H-(HCHO)]− precursor ion of prednisolone and the target (m/z 295)
and qualifier fragment ions (m/z 280, 187). The chromatographic retention time of prednisolone is 16.43 min
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des Reines”, a traditional bloodless tournament in which
animals are allowed to fight spontaneously to assess dom-
inance. In contrast, the cited study by De Clercq and co-
workers [11] reported the detection of prednisolone, along
with its 20α- and 20β-dihydroderivatives, in the urine of
“artificially stressed” cows, subjected to i.m. treatment
with tetracosactide, a synthetic ACTH analogue.
Although the urine of the cows undergoing such a
pharmacological treatment exhibited the occurrence
of natural corticoids levels similar to those found in
slaughtered cows, no plausible explanation was pro-
vided to justify the apparent discrepancy between
absence and presence of prednisolone in naturally
and artificially stressed animals, respectively. More
recently, van Meulebroek et al. [10] reported the de-
tection of 20β-dihydroprednisolone in all urine speci-
mens collected from cows subjected to prednisolone
treatment, under either therapeutic or (oral) growth-
promoting schedule, as well as in cows treated (by i.m.
injection) with tetracosactide to induce a pharmacological
stress. In the latter paper, however, the relative increase in
urinary cortisol and cortisone concentrations with respect
to T0 values (i.e., prior to tetracosactide administration)
was uniquely reported, so that a direct comparison with
the absolute levels of natural corticoids recorded in
naturally stressed cows [11] is not feasible. Based on the
evidences presently available, the reasons for the seem-
ingly different urinary pattern profile of prednisolone
metabolites between naturally and artificially stressed
cows remain to be elucidated. As a matter of fact, besides
the cases of pharmacologically-induced stress, the pres-
ence of 20β-dihydroprednisolone and other prednisolone
metabolites in the cattle urine has been so far consistently
associated only with the exogenous administration of the
parent drug, either following a growth-promoting protocol
or a therapeutic schedule [8, 10, 13].
Earlier investigations disclosed that in-vitro cortisol
incubation with bacteria [11] and bovine hepatic S9
preparations [3] resulted in the progressive decrease of
cortisol along with the generation of prednisolone. This
finding suggests that the liver is possibly the involved
organ for the endogenous prednisolone synthesis. In
the present study, neither prednisolone nor its dihydro-
derivatives could be detected in any liver sample of the
slaughtered cows, including the two of them displaying
the presence of urinary prednisolone. In addition, traces
of cortisol corresponding to about 1 μg Kg− 1 were
detected in only one liver sample. This important
evidence apparently indicate that transport and slaugh-
tering stressing conditions are not associated with any
significant increase of hepatic cortisol concentration,
partly contradicting what was observed in the in-vitro
investigations using much higher cortisol concentra-
tions (5 mM).
In a study characterized by an experimental design
similar to the present one [9], measurable amounts of
prednisolone were detected in about one third of the
analysed adrenal glands along with high levels of corti-
sol. In our study, only one sample was found to contain
prednisolone (3.4 μg Kg− 1) along with relatively high
concentrations of cortisol (185 μg Kg− 1) and cortisone
(437 μg Kg− 1), but further five samples with similar or
even much higher concentration of both natural corti-
coids did not show the presence of prednisolone at any
level. In agreement with the observations of Bertocchi et
al. [9], no correlation was found between the presence of
prednisolone in the adrenal glands and in urine, suggest-
ing that the endogenous synthesis of prednisolone is a
complex phenomenon possibly involving different
organs and tissues other than liver and adrenal glands.
Conclusions
This study confirms the sporadic presence of prednisol-
one traces (2 out 15) and the consistently increased
concentration of cortisone and cortisol in the urines
collected from cows subjected to truck transportation
and subsequent slaughtering. The detected prednisolone
levels were found much below the official cut off of
5.0 μg L− 1 established to avoid false non-compliances.
Based on the results of this and other studies [11, 14], it may
also be concluded that, in cows subjected to various natural
sources of stress, the occasional positive finding of urinary
endogenous prednisolone is never matched by the presence
of 20β-dihydroprednisolone or any other prednisolone me-
tabolite. It is also evident that this irregular endogenous
prednisolone biosynthesis cannot be directly attributed to a
specific organ (liver or adrenal glands) and further research
is needed to ascertain the possible sites of endogenous pred-
nisolone synthesis in naturally stressed cows.
An evident limitation of the present study is the lack of
standardization for the cattle transportation conditions to
the abattoir, that introduces a potentially uncontrolled
influencing factor possibly enhancing the correlated stress
variability. While this limitation was inherently associated
with the study commitment to investigate only cows at the
end of their (re) productive cycle, making slaughtering by
no means compelled by the scientific purpose to obtain
more homogeneous experimental conditions, it is apparent
that future development of the present study should more
accurately model the stressing factors associated to cattle
transport, including truck type, duration, distance, road
conditions, and temperature and humidity environment.
Methods
Urine, liver and adrenal gland collection
Fifteen clinically healthy Piedmontese or Friesian cows
(age range 8–14 years, average weight around 600 kg)
were enrolled in the study, which was conducted
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between mid- April and May. The monthly temperature
in Piedmont, averaged for location, day and hour was
9.5 °C in April and 12.8 °C in May [15]. All cows were at
the end of their (re) productive cycle and ready for
slaughter. They were bred in two conventional farms
(40–200 animals, respectively) located in the Turin and
Cuneo provinces of Piedmont (northern Italy) and kept
in tie stall barns. Farms were selected according to
personal records and breeder formal declaration that the
cows had not been subjected to any drug treatment in
the last 30 days prior to sampling procedures, at least.
Urine samples were first collected at farms under condi-
tions of natural micturition, taking care to prevent faecal
contamination. After 2 to 3 days, the animals were trans-
ported [16] to the abattoir (40 and 80 km journey from
the two farms to the abattoir, on plain roads using single
level trucks, with no facilities for measuring temperature
and humidity). Transport was carried out according to
Council Regulation (EC) N. 1/2005 and cows were
slaughtered 30 to 45 min after the arrival. The animals
were first desensitized with a captive-bolt pistol and then
exsanguinated in the conventional way. Post-mortem
sampling of liver and adrenal glands was performed by
licensed veterinarians within 15 min from slaughtering,
together with urine from the urinary bladder. After
collection, all samples were immediately refrigerated
(put on ice), frozen at − 20 °C within 4 h, and subse-
quently conferred to the analytical laboratory. The whole
study was conducted under the strict control of the
Regional Veterinary Public Services of Torino and
Cuneo (Piedmont, Italy).
Chemicals, reagents, and standard solutions
Diethylether and acetonitrile together with cortisone, corti-
sol, prednisone, and prednisolone analytical standards were
supplied by Sigma–Aldrich (St. Louis, MO, USA). All
solvents were of analytical grade. 20α-dihydroprednisolone,
20β-dihydroprednisolone, 6β-hydroxyprednisolone, and
20β-dihydroprednisone were supplied by Steraloids
(Newport, RI, USA). Cortisol D2, cortisone D2, and prednis-
olone D6 were purchased from C/D/N Isotopes Inc.
(Pointe-Claire, Quebec, Canada). Triamcinolone acetonide
D6 was from RIVM (Bilthoven, The Nederlands). So-
dium hydroxide and hydrochloric acid were supplied by
Carlo Erba Reagenti (Milan, Italy). Betaglucuronidase/
aryl-sulfatase was from Roche Diagnostics (Mannheim,
Germany). Ultrapure water was obtained by a Milli-Q
Millipore system (Bedford, MA, U.S.A.).
Stock standard solutions of the analytes were pre-
pared in acetonitrile at a concentration of 1 mg L− 1 and
stored at − 20 °C in the dark. Working acetonitrile solu-
tions containing all the analytes at different concentra-
tions were prepared by proper dilution. The working
solutions were used to spike negative urine samples for
the validation of the analytical method.
Sample preparation
Urine
Sample preparation was conducted as reported else-
where (Vincenti et al. 2012). Briefly, 5 mL urine samples
were subjected to a liquid/liquid extraction at pH = 8.5–
9.5 with diethylether, after β-glucuronidase/arylsulfatase
deconjugation. After centrifugation, the supernatant or-
ganic phase was transferred into a 10mL glass tube and
evaporated to dryness under nitrogen with 40 °C heating.
The residue was dissolved in 50 μL of a water:aceto-
nitrile mixture (70:30 v/v) solution and transferred into
the analytical vials for the analysis.
Liver/adrenal gland
Sample aliquots of 2.5 g were homogenized in 5 ml acet-
ate buffer and then added with 50 μL of the internal
standard mix solution at 0.1 ng L− 1. Further acetate buf-
fer 0.1 M was added (5 mL; pH = 5) and the extraction
was carried out by 5min shaking plus 5 min ultrasonic
bath. After centrifugation (3500 rpm for 5 min), the
aqueous phase was extracted with 10 mL of tert-butyl
methyl ether. The organic phase was transferred into a
10mL glass tube and evaporated to dryness under a
gentle stream of nitrogen and mild heating (50 °C). For
adrenal glands, a further washing step was executed to
remove fat. The residue, dissolved in 2 mL acetonitrile,
was washed with 2 mL of hexane and dried again. The
residue was dissolved again in 50 μL of a water:aceto-
nitrile mixture (70:30 v/v) solution and transferred into
the analytical vial.
Instrumental analysis
All the samples were analysed by LC-MS/MS using the
method previously described by Cannizzo et al. [17], and
further implemented by Vincenti et al. [7] and Leporati
et al. [13]. An Agilent 1100 LC was interfaced to an
Applied Biosystems API 4000 triple quadrupole mass
spectrometer (Applied Biosystems Sciex, Ontario, Canada),
operating in atmospheric pressure chemical ionization
(APCI). Each sample was analysed twice and quantified by
means of a calibration curve, using internal standard
correction.
For the urine and adrenal gland samples that were
found positive to prednisolone at concentrations lower
than the CCα (i.e., matching the prednisolone reference
standard in terms of retention time and presence and
relative abundance of the product ions), the correct
identification of prednisolone was further confirmed by
reprocessing the samples under a different MS/MS ac-
quisition method. Following the procedure described by
Savu and coworkers [18], the APCI source was operated
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in the negative ion mode under high declustering poten-
tial (DP), which induced an “in-source” fragmentation of
the deprotonated molecular ion (M-H)− yielding a loss
of formaldehyde (HCHO; 30 Da) from the (C21) hy-
droxymethyl group and the formation of the [M-H-
(HCHO)]− precursor ion with considerable abundance.
The latter was subsequently fragmented under selected
reaction monitoring (SRM) conditions. The experimen-
tal settings are reported in Table 3.
Method validation
For urine and liver samples, the method was validated ac-
cordingly to 2002/657/CE Decision (2002/657 CE Decision)
for prednisone and prednisolone [17]. For other analytes a
simplified validation protocol was applied [7, 13].
For the screening analysis of the adrenal glands a new
and simplified validation protocol was executed. This
matrix is not adopted for the official controls of the
Italian National Residue Plan [19]. SRM transitions with
corresponding potentials for target compounds and
internal standards are reported in Table 4.
Since cortisol is synthesized from cholesterol in the
zona fasciculata of the adrenal cortex, no blank matrix
for cortisol and cortisone is available, forcing us to build
the calibration curves from standard solutions.
The assessment of specificity, linearity, precision, ac-
curacy was included in the validation procedure.
Specificity
Ten adrenal glands were extracted and analysed as de-
scribed above. The occurrence of possible interferences
from endogenous substances was tested by monitoring
the SRM profiles characteristic for each investigated
compound, at the retention time interval expected for
their elution.
Linearity
The instrumental linearity was studied to estimate if the
quantification range of the method is encompassed by
the instrumental dynamic linear range. Five concentra-
tions of each analyte pure standard solutions (0, 25, 50,
100, 250, 500 μg L− 1 for prednisone and prednisolone, 0,
Table 3 Instrumental parameters for prednisone and prednisolone using the confirmation method based on negative APCI and “in
source” collisional fragmentation of the deprotonated molecular ion to yield the [M-H-(HCHO)]− precursor ion
MS parameters CUR = 20 psi CAD = 2 psi
GS1 = 50 psi T = 300 °C
NC = - 3 V ihe = ON
SRM protocol Target Qualifier 1 Qualifier 2
Analyte Precursor Ion DP (V) Fragment CE (V) Fragment (qualifier 1/quantifier %) CE (V) Fragment (qualifier 2/quantifier %) CE (V)
Prednisolone 329.1 −96 295.4 −25 280.2 90% −31 187.1 81% −25
Prednisone 327.2 −90 149.2 −39 285.4 45% −25 270.3 26% −28
CUR curtain gas, GS1 nebulizer gas, NC nebulizer current, CAD collision gas, T temperature, ihe interface heater, DP declustering potential, CE collision energy
Table 4 Instrumental conditions used for validating the analytical method and subsequently used in the screening of adrenal gland
Analyte (correspondent IS in
brackets)
tR (min) Precursor Ion DP (V) Target Qualifier
Fragment CE (V) Fragment (qualifier/quantifier %) CE (V)
6β-hydroxyprednisolone (A) 4.78 377.1 47 341.1 11 323.2 28% 15
20α-dihydroprednisolone (A) 11.28 363.3 37 345.2 15 309.3 75% 18
20β-dihydroprednisolone (A) 12.58 363.3 37 345.2 15 309.3 24% 18
20β-dihydroprednisone (A) 12.87 361.3 55 153.0 21 313.2 54% 16
Prednisolone (A) 17.16 361.3 55 343.3 16 325.3 38% 16
Prednisone (A) 17.68 359.1 70 341.1 17 313.2 41% 19
Cortisol (B) 17.72 363.2 69 121.3 33 147.3 67% 44
Cortisone (C) 18.64 361.2 83 163.4 36 105.3 14% 64
Internal standards
A Prednisolone D6 16.95 367.1 48 330.3 16 – – –
B Cortisol D2 17.68 365.2 65 121.8 39 – – –
C Cortisone D2 18.61 363.1 67 165.1 34 – – –
DP Declustering Potential, CE Collision Energy
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100, 250, 500, 750, 1000 μg L− 1 for prednisolone and pred-
nisone metabolites, and 0, 0.5, 1.25, 2.5, 5, 12.5mg L− 1 for
cortisol and cortisone) were injected, to set up the
linearity testing curves. Each level was injected in
triplicate.
Precision and trueness
Intraday precision (expressed as percent variation coeffi-
cient, CV%) and trueness (expressed as bias%) were
evaluated at three concentration levels: 0.5, 2 and 10 μg
Kg− 1 for prednisone and prednisolone, 2, 10 and 20 μg
Kg− 1 for prednisone and prednisolone metabolites. Five
replicates of adrenal gland samples were spiked with the
standard solutions at three concentration levels. Intraday
precision was considered satisfactory when CV% values
were below 15%. Satisfactory trueness was achieved
when the experimentally determined average concentra-
tion lied within ±15% from the expected value.
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